Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-29
2005-11-29
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253040, C514S254060, C514S249000, C514S303000, C514S395000, C540S575000, C544S350000, C544S362000, C546S118000, C548S306100
Reexamination Certificate
active
06969712
ABSTRACT:
This invention relates to the compounds represented by a general formula [I]:[in which A1and A2represent optionally fluorine-substituted methine or the like; B represents halogen, cyano, lower alkyl or the like; D represents optionally substituted heterocyclic group or the like; and G represents C3-C20aliphatic group such as alicyclic group]. These compounds inhibit nociceptin activities due to their high affinity to nociceptin receptor, and are useful as analgesic, antiobestic, corebral function improver, drugs for treatment of alzheimer's disease and dementia, remedies for schizophrenia and neurodegenerative diseases, antidepressant, remedies for diabetes insipidus, polyuria, hypotension and so on.
REFERENCES:
patent: 5554631 (1996-09-01), Kim et al.
patent: 6051570 (2000-04-01), Lohray et al.
patent: 0 963 987 (1999-12-01), None
patent: 1 072 263 (2001-01-01), None
patent: 63-91385 (1988-04-01), None
patent: 2-306916 (1990-12-01), None
patent: 2001-58991 (2001-03-01), None
patent: 99/36421 (1999-07-01), None
patent: 99/59997 (1999-11-01), None
patent: 00/27815 (2000-05-01), None
patent: 00/08013 (2002-02-01), None
Zaveri N., Life Sci. Jun. 27, 2003;73(6):663-78.
Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D., Br J Pharmacol. Apr. 2000;129(7):1261-83.
Paquette, Leo A., Principles of Modern Heterocyclic Chemistry, W.A. Benjamin, New York, 1968, p. 241.
N. Murphy et al., Neuroscience, vol. 75(1), pp. 1-4 (1996).
J. Mogil, Neuroscience, vol. 75(2), pp. 333-337 (1996).
D. Kapusta et al., “Life Science”, vol. 60(1), pp. PL15-PL-22 (1997).
B. Gumusel et al., “Life Science”, vol. 60(8), pp. PL141-PL145 (1997).
H. Ueda et al., Neuroscience Letters, vol. 237, pp. 136-138 (1997).
T. Manabe et al., “Nature”, vol. 394, pp. 577-581 (1998).
Meunier et al., “Nature”, vol. 377, pp. 532-535 (1995).
A. Levine, “Society for Neuroscience”, vol. 22, p. 455 (1996).
R. Stratford et al., “NeuroReport”, vol. 8(2), p. 423-426 (1997).
J. Sandin et al., “European Journal of Neuroscience”, vol. 9, pp. 194-197 (1997).
Itoh Satoru
Iwasawa Yoshikazu
Kato Tetsuya
Kawamoto Hiroshi
Kobayashi Kensuke
Banyu Pharmaceutical Co. Ltd.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3475016